DE3226320C2 - - Google Patents

Info

Publication number
DE3226320C2
DE3226320C2 DE3226320A DE3226320A DE3226320C2 DE 3226320 C2 DE3226320 C2 DE 3226320C2 DE 3226320 A DE3226320 A DE 3226320A DE 3226320 A DE3226320 A DE 3226320A DE 3226320 C2 DE3226320 C2 DE 3226320C2
Authority
DE
Germany
Prior art keywords
serum
cells
medium
plasminogen activator
conditioning
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3226320A
Other languages
German (de)
English (en)
Other versions
DE3226320A1 (de
Inventor
Zvi Rehovot Il Bohak
Avinoam Petach Tikvah Il Kadouri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Publication of DE3226320A1 publication Critical patent/DE3226320A1/de
Application granted granted Critical
Publication of DE3226320C2 publication Critical patent/DE3226320C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE19823226320 1981-07-15 1982-07-14 Plasminogenaktivator und verfahren zu seiner herstellung Granted DE3226320A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL63317A IL63317A (en) 1981-07-15 1981-07-15 Production of plasminogen activator

Publications (2)

Publication Number Publication Date
DE3226320A1 DE3226320A1 (de) 1983-02-10
DE3226320C2 true DE3226320C2 (enExample) 1989-08-17

Family

ID=11052764

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19823226320 Granted DE3226320A1 (de) 1981-07-15 1982-07-14 Plasminogenaktivator und verfahren zu seiner herstellung

Country Status (6)

Country Link
JP (1) JPS5865219A (enExample)
DE (1) DE3226320A1 (enExample)
FR (1) FR2510604B1 (enExample)
GB (1) GB2104081B (enExample)
IL (1) IL63317A (enExample)
IT (1) IT1195939B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5951220A (ja) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
JPS60158115A (ja) * 1984-01-30 1985-08-19 Meiji Milk Prod Co Ltd プラズミノーゲンアクチベーターの製造法
JPS60259187A (ja) * 1984-04-19 1985-12-21 マイルス・ラボラトリ−ス・インコ−ポレ−テツド プラスミノーゲン活性化因子を増収する方法
EP0163751B1 (en) * 1984-06-05 1989-09-20 Asahi Kasei Kogyo Kabushiki Kaisha Process for the preparation of a plasminogen activator
US4550080A (en) * 1984-06-05 1985-10-29 Asahi Kasei Kogyo Kabushiki Kaisha Process for the preparation of a plasminogen activator
US5210037A (en) * 1988-03-22 1993-05-11 Centocor Incorporated Method to enhance TPA production
AU3364589A (en) * 1988-03-22 1989-10-16 Invitron Corporation Method to enhance tpa production
DE4128953A1 (de) * 1991-08-30 1993-03-04 Basf Ag Verfahren zur kultivierung von saeugerzellen im fliessbettreaktor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232124A (en) * 1979-04-23 1980-11-04 Mann George F Method of producing plasminogen activator
JPS55144887A (en) * 1979-04-26 1980-11-12 Asahi Chem Ind Co Ltd Preparation of physiologically active substance

Also Published As

Publication number Publication date
JPH0137115B2 (enExample) 1989-08-04
JPS5865219A (ja) 1983-04-18
IT8222392A1 (it) 1984-01-14
FR2510604B1 (fr) 1985-07-12
IL63317A (en) 1985-05-31
GB2104081A (en) 1983-03-02
IT8222392A0 (it) 1982-07-14
DE3226320A1 (de) 1983-02-10
IT1195939B (it) 1988-11-03
GB2104081B (en) 1985-06-12
FR2510604A1 (fr) 1983-02-04
IL63317A0 (en) 1981-10-30

Similar Documents

Publication Publication Date Title
DE3783643T2 (de) Anheftende biomaterialien fuer die adhaesion von zellen und geweben.
DE2651685C2 (de) Züchtung von Keratinozyten
JPS60500400A (ja) 組織培養培地
DE3027105A1 (de) Verfahren zur herstellung eines die proliferation und differenzierung menschlicher granulopoetischer stammzellen stimulierenden faktors
DE2940150A1 (de) Mikrotraeger-zellkultur
EP0325190A2 (de) Pentosansulfat-Medium
DE2314076C3 (de) Verfahren zur Herstellung von karzinoembyonischem Antigen
DE3226320C2 (enExample)
DE3538310A1 (de) Verwendung von glutamin in form seiner di- und tripeptide im naehrmedium fuer zellkulturen
Tumosa et al. Putative cholinergic interneurons in the optic tectum of goldfish
DE60216906T2 (de) Anti-pilyrosporum ovale igy und dessen verwendung
DE2828073C2 (de) Verfahren zum Kultivieren von Viren
EP0006671A2 (de) Verfahren zur Erhaltung lebender Mikroorganismen
EP0517789B1 (de) Inhibitor der proliferation von endothelzellen
EP0065246A2 (de) Verfahren zur Gewinnung anaboler, atmungsfördernder, niedermolekularer Wirkstoffe für prophylaktische, therapeutische, zell- und gewebekulturtechnische Zwecke
DE68913602T2 (de) Gewebe-Immobilisierungs- und Zellkultursystem und Verfahren zum Anbringen biologisch wirksamer Teile an einem Substrat.
Watanabe CHANGES IN THE CAPACITY FOR CLONAL GROWTH AND DIFFERENTIATION IN VITRO OF THE VERTEBRAL CARTILAGE CELLS WITH EMBRYONIC DEVELOPMENT II. VITALIZING EFFECT OF CONDITIONED MEDIUM ON THE CELLS OF YOUNGER EMBRYOS
DE69633604T2 (de) Flüssigmedium für nervenzellen, verfahren für dessen herstellung und eine methode für die inkubation von nervenzellen unter verwendung desselben
DE3539702C2 (enExample)
Steeves et al. In vitro cultures of a fern callus
DE4115029C2 (enExample)
Krise Optimum protease exposure time for removing adhesiveness of walleye eggs
DE3239863A1 (de) Verfahren zur herstellung von subkultivierbaren lymphokin-bildenden human-t-zellenhybridomas
DE10333863A1 (de) Bioartifizielles, primär vaskularisiertes Testgewebe für pharmakologische Testverfahren, Verfahren zu dessen Herstellung und Testverfahren unter dessen Verwendung sowie Bioreaktor zur Durchführung der Verfahren
Parker THE RACES THAT CONSTITUTE THE GROUP OF COMMON FIBROBLASTS: II. THE EFFECT OF BLOOD SERUM

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee